e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Bronchiolitis obliterans: new developments in investigating post-transplant airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clarithromycin has a preventive effect on chronic graft rejection
K. F. Remund, Z. Guo, M. Hofer, T. Rechsteiner, P. Vogt, E. W. Russi, A. Boehler (Zurich, Switzerland)
Source:
Annual Congress 2004 - Bronchiolitis obliterans: new developments in investigating post-transplant airway disease
Session:
Bronchiolitis obliterans: new developments in investigating post-transplant airway disease
Session type:
Oral Presentation
Number:
2915
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. F. Remund, Z. Guo, M. Hofer, T. Rechsteiner, P. Vogt, E. W. Russi, A. Boehler (Zurich, Switzerland). Clarithromycin has a preventive effect on chronic graft rejection. Eur Respir J 2004; 24: Suppl. 48, 2915
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Immunosuppressive therapy after human lung transplantation
Source: Eur Respir J 2004; 23: 159-171
Year: 2004
The impact of long-term azithromycin on antibiotic resistance in HIV-associated chronic lung disease
Source: ERJ Open Res, 8 (1) 00491-2021; 10.1183/23120541.00491-2021
Year: 2022
Immunosuppressive therapy after human lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=105
Year: 2003
The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Efficacy and safety of various antimicrobial regimens in the treatment of acute exacerbations of chronic bronchitis
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007
Basiliximab induction reduces the incidence of acute rejection in lung transplant patients
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
Comparison of the efficacy of azythromycin and roxithromycin in the treatment of acute purulent exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 138s
Year: 2001
The efficacy and treatment length of oral corticosteroids in patient with acute exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 295s
Year: 2005
The efficacy of anti-fibrotic agents for acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017
Why short-term antibiotic use in AECB may influence long-term outcomes
Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI
Year: 2005
Long-term benefits of antibiotic treatment in reducing recurrence rates and resource utilization in acute exacerbations of chronic bronchitis (AECB)
Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD
Year: 2003
A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
Source: Eur Respir J 2011; 37: 164-172
Year: 2011
Mycophenolate mofetil reduces alveolar inflammation and acute rejection and improves overall outcome after lung transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 724s
Year: 2006
Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation
Source: Eur Respir J 2001; 18: Suppl. 33, 298s
Year: 2001
Efficacy and safety of moxifloxacin in the outpatient treatment of exacerbations of chronic obstructive pulmonary disease
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
Telithromycin is effective in the treatment of patients with acute exacerbations of chronic bronchitis and risk factors for morbidity
Source: Eur Respir J 2002; 20: Suppl. 38, 545s
Year: 2002
Acute exacerbation of bronchiectasis and the impact on the duration of antibiotic therapy
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
Five-day telithromycin is as effective as 10-day clarithromycin in the treatment of acute exacerbations of chronic bronchitis
Source: Eur Respir J 2003; 22: Suppl. 45, 351s
Year: 2003
Fenspiride as complementary anti-inflammatory agent in therapy of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD management
Year: 2011
CT findings before and after azithromycin treatment of chronic lung allograft dysfunction
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept